Insight

Bouthaina Dabaja: Target nomenclature for lymphoma trials

Collage photo of Bouthaina Dabaja and Omran Saifi

Oct 6, 2024, 12:47

Bouthaina Dabaja: Target nomenclature for lymphoma trials

Bouthaina Dabaja, Radiation Oncologist at MD Anderson Cancer Center, shared a post on X about a recent paper by Omran Saifi et al. published in The Lancet Hematology.

“Radiation target nomenclature for lymphoma trials: consensus recommendations from the National Clinical Trials Network groups”

Authors: Omran Saifi, Chelsea Pinnix, Leslie Ballas, David Hodgson, Bradford Hoppe et al.

“A superb document by Omran Saifi, Bradford Hoppe on RT target nomenclature for lymphoma trials.”

Source: Bouthaina Dabaja/X

Bouthaina Dabaja Bradford Hoppe cancer Chelsea Pinnix David Hodgson Leslie Ballas lymphoma MD Anderson Cancer Center Omran Saifi OncoDaily Oncology The Lancet Hematology

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage